Sun Pharma Advanced Research Company Limited
SPARC.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$60.23B
Close$
Share Statistics
| Market cap | $60.23 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (-) |
| Earnings per Share | $47.86 |
| Beta | 0.65 |
| Outstanding Shares | 324,521,588 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 3.8 |
|---|---|
| PEG | -6.34 |
| Price to Sales | 3.2 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Sun Pharma Advanced Research Company Limited
279 employees
CEO: Anilkumar Raghavan Sun Pharma Advanced Research Company Limited (SPARC) is a biopharmaceutical firm dedicated to the research and development of innovative pharmaceutical solutions, operating both within India and globally. Its therapeutic focus encompasse...